Management of Drug-Induced Parkinsonism

Diagnosis and Clinical Presentation

• When diagnostic uncertainty exists, dopaminergic imaging (DaTscan) may assist in differentiating drug-induced from neurodegenerative parkinsonism 2

Management Algorithm

• The American Academy of Sleep Medicine recommends drug discontinuation over drug continuation for drug-induced REM sleep behavior disorder specifically 3
• Switching to an agent with lower risk of parkinsonism (e.g., quetiapine or clozapine for antipsychotics) is considered when complete discontinuation is not possible 4

Pharmacological Management When Discontinuation Is Not Possible

• Trihexyphenidyl is indicated for drug-induced parkinsonism with a total daily dosage usually ranging between 5-15 mg 1
• Anticholinergic medications, such as trihexyphenidyl, are most effective for tremor and rigidity components of DIP 1
• Use of anticholinergic medications should be with caution in elderly patients due to potential cognitive side effects 1

Special Considerations

• Regular monitoring using standardized scales like the Abnormal Involuntary Movement Scale (AIMS) is recommended every 3-6 months 4, 1
• In patients with psychiatric conditions requiring antipsychotics, carefully balance the risk of psychotic relapse against the severity of parkinsonian symptoms 4

Prevention

• A "start low, go slow" approach to medication dosing, particularly in vulnerable populations, is recommended 2
• Perform baseline and periodic assessments using standardized scales to detect early parkinsonian symptoms 4, 1
• Monitor calcium levels, as hypocalcemia may induce or worsen movement disorders 2, 5